Translational Development Acquisition Corp
TDACU11.000USD
0.0000.00%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Translational Development Acquisition Corp Company
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
Translational Development Acquisition Corp Info
Ticker SymbolTDACU
Company nameTranslational Development Acquisition Corp
IPO dateDec 23, 2024
CEOHoffman (Michael B)
Number of employees- -
Security typeUnit
Fiscal year-end- -
Address52 E 83Rd St.
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10028
Phone14132042769
Website
Ticker SymbolTDACU
IPO dateDec 23, 2024
CEOHoffman (Michael B)
Company Executives of Translational Development Acquisition Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Nov 12
Updated: Wed, Nov 12
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Calamos Advisors LLC
2.17%
D. E. Shaw & Co., L.P.
2.03%
Schechter Investments
0.87%
RiverNorth Capital Management LLC
0.58%
Yakira Capital Management, Inc.
0.35%
Other
94.00%
Shareholders
Shareholders
Proportion
Calamos Advisors LLC
2.17%
D. E. Shaw & Co., L.P.
2.03%
Schechter Investments
0.87%
RiverNorth Capital Management LLC
0.58%
Yakira Capital Management, Inc.
0.35%
Other
94.00%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
2.78%
Hedge Fund
2.03%
Investment Advisor
1.27%
Research Firm
0.09%
Other
93.83%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
46
1.06M
6.17%
-13.84M
2025Q3
47
2.55M
14.76%
-12.35M
2025Q2
46
4.08M
23.66%
-10.95M
2025Q1
45
4.60M
26.65%
-10.31M
2024Q4
41
14.94M
86.63%
+14.94M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Calamos Advisors LLC
375.00K
2.17%
--
--
Sep 30, 2025
D. E. Shaw & Co., L.P.
350.00K
2.03%
--
--
Sep 30, 2025
Schechter Investments
150.64K
0.87%
--
--
Mar 31, 2025
RiverNorth Capital Management LLC
100.00K
0.58%
-400.00K
-80.00%
Sep 30, 2025
Yakira Capital Management, Inc.
60.00K
0.35%
--
--
Sep 30, 2025
Flow Traders U.S. LLC
15.79K
0.09%
+1.56K
+10.96%
Sep 30, 2025
UBS Financial Services, Inc.
8.33K
0.05%
--
--
Sep 30, 2025
AQR Arbitrage, LLC
3.95K
0.02%
+3.95K
--
Dec 31, 2024
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
SPAC and New Issue ETF
0%
SPAC and New Issue ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Translational Development Acquisition Corp?
The top five shareholders of Translational Development Acquisition Corp are:
Calamos Advisors LLC holds 375.00K shares, accounting for 2.17% of the total shares.
D. E. Shaw & Co., L.P. holds 350.00K shares, accounting for 2.03% of the total shares.
Schechter Investments holds 150.64K shares, accounting for 0.87% of the total shares.
RiverNorth Capital Management LLC holds 100.00K shares, accounting for 0.58% of the total shares.
Yakira Capital Management, Inc. holds 60.00K shares, accounting for 0.35% of the total shares.
Calamos Advisors LLC holds 375.00K shares, accounting for 2.17% of the total shares.
D. E. Shaw & Co., L.P. holds 350.00K shares, accounting for 2.03% of the total shares.
Schechter Investments holds 150.64K shares, accounting for 0.87% of the total shares.
RiverNorth Capital Management LLC holds 100.00K shares, accounting for 0.58% of the total shares.
Yakira Capital Management, Inc. holds 60.00K shares, accounting for 0.35% of the total shares.
What are the top three shareholder types of Translational Development Acquisition Corp?
The top three shareholder types of Translational Development Acquisition Corp are:
Calamos Advisors LLC
D. E. Shaw & Co., L.P.
Schechter Investments
Calamos Advisors LLC
D. E. Shaw & Co., L.P.
Schechter Investments
How many institutions hold shares of Translational Development Acquisition Corp (TDACU)?
As of 2025Q4, 46 institutions hold shares of Translational Development Acquisition Corp, with a combined market value of approximately 1.06M, accounting for 6.17% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -8.59%.
What is the biggest source of revenue for Translational Development Acquisition Corp?
In --, the -- business generated the highest revenue for Translational Development Acquisition Corp, amounting to -- and accounting for --% of total revenue.
